Quidel Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Quidel Corp (QDEL) Tops Q1 EPS by 24c, Revenues Beat
May 6, 2020 5:57 PM EDTQuidel Corp (NASDAQ: QDEL) reported Q1 EPS of $1.22, $0.24 better than the analyst estimate of $0.98. Revenue for the quarter came in at $174.7 million versus the consensus estimate of $158.08 million.
First Quarter 2020 Highlights
Total revenue increased 18% to $174.7 million, from $148.0 million in the first quarter of 2019.Cardiometabolic Immunoassay revenue decreased 18% to $53.9 million, and decreased 17% on a constant currency basis.Molecular Diagnostic Solutions revenue grew 45% from the first quarter of 2019 to $8.4 million.Influenza revenue... More